Boundless Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect 2021 Conference
Boundless Bio , a biotechnology company developing innovative therapeutics directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today announced that Zachary Hornby, President and Chief Executive Officer of Boundless Bio, will present at the 39th Annual J.P. Morgan Healthcare Conference and the H.C. Wainwright BioConnect 2021 Conference.
Boundless Bio, a biotechnology company developing innovative therapeutics directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today announced that Zachary Hornby, President and Chief Executive Officer of Boundless Bio, will present at the 39th Annual J.P. Morgan Healthcare Conference and the H.C. Wainwright BioConnect 2021 Conference.
Presentation details are as follows:
39th Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 13, 2021
Time: 4:20 p.m. EST
H.C. Wainwright BioConnect 2021 Conference
Date: Monday, January 11, 2021
Time: 6:00 a.m. EST (available on demand)
About Boundless Bio
Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.
For more information, visit www.boundlessbio.com.
Follow us on LinkedIn and Twitter.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210106005216/en/